EUVIMEDEUVIMED entdecken
Crossref

Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer

Klara Vokacova, Aneta Landecka, Saba Selvi, Josef Horak, Vendula Novosadova, Katerina Manakova, Miroslav Levy, Veronika Vymetalkova iD

Mutagenesis · 2025

DOI: 10.1093/mutage/geae023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mutagenesis, 2025. Verfasst von Klara Vokacova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Colonic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance represents a major issue affecting cancer therapy efficacy. Because microRNAs (miRNAs) regulate gene expression on multiple levels, their role in chemoresistance development is reasonably certain. In our previous study, miR-122-5p and miR-142-5p were identified as diagnostic, prognostic, and predictive biomarkers for primary and metastatic rectal cancer. The aim of the present study was to investigate whether these miRNAs can also reflect the disease course of patients with colon cancer (CC). Further, we focused on a deeper understanding of their involvement in 5-fluorouracil (5-FU) chemoresistance development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrug Resistance, NeoplasmColonic NeoplasmsHumansFluorouracilMaleFemaleMiddle AgedBiomarkers, TumorAgedGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

MicroRNAbiomarkerchemoresistancecolon cancerliquid biopsy

Substanzen

MicroRNAsMIRN142 microRNA, humanFluorouracilMIRN122 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, 142 20, Czech Republic.
  • 1st Medical Faculty, Institute of Biology and Medical Genetics, Charles University, Prague, 142 20, Czech Republic.
  • Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, 128 00, Czech Republic.
  • Third Faculty of Medicine, Charles University, Ruska 87, Prague, 10000, Czech Republic.
  • Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Prague, 252 50, Czech Republic.
  • 1st Medical Faculty, Charles University, Prague, 142 20, Czech Republic.

ORCID-Profile: Veronika Vymetalkova

Zitieren

APA

Vokacova, K., Landecka, A., Selvi, S., Horak, J., Novosadova, V., Manakova, K., Levy, M., & Vymetalkova, V. (2025). Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer. Mutagenesis. https://doi.org/10.1093/mutage/geae023

Vancouver

Vokacova K, Landecka A, Selvi S, Horak J, Novosadova V, Manakova K, et al. Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer. Mutagenesis. 2025. doi:10.1093/mutage/geae023

BibTeX
@article{Vokacova2025,
  author = {Vokacova, Klara and Landecka, Aneta and Selvi, Saba and Horak, Josef and Novosadova, Vendula and Manakova, Katerina and Levy, Miroslav and Vymetalkova, Veronika},
  title = {Plasma miR-122-5p and miR-142-5p and their role in chemoresistance of patients with colon cancer},
  journal = {Mutagenesis},
  year = {2025},
  doi = {10.1093/mutage/geae023}
}
Kostenlos starten →